US equities |
INTC $92.07 ▲+0.00% SNDK $1,330.05 ▲+0.00% MU $934.27 ▲+0.00% NVDA $213.66 ▲+0.00% GOOGL $283.82 ▲+0.00% SKHY $162.09 ▲+0.00% AMZN $243.79 ▲+0.00% AMD $566.42 ▲+0.00%
FinancialContent

Evaxion A/S - American Depositary Share (NQ:EVAX)

3.080 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evaxion A/S - American Depositary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Evaxion announces business update and third quarter 2024 financial results
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Biotech Partners With Merck To Expand Vaccine Development ↗
Evaxion Biotech enters an expanded collaboration with Merck, granting an option to license preclinical vaccine candidates. The deal includes $3.2 million upfront and potential earnings up to $592... 
Via Benzinga
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Recap: Evaxion Biotech Q4 Earnings ↗
 
Via Benzinga
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q2 2024 ↗
EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Evaxion Announces Business Update and Second Quarter 2024 Financial Results
From Evaxion Biotech
Via GlobeNewswire
News headline image
iAccess Alpha's Buyside Best Ideas Virtual Summer Conference June 25-26, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q1 2024 ↗
EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Evaxion Announces Business Update and First Quarter 2024 Financial Results
From Evaxion Biotech
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
From Evaxion Biotech
Via GlobeNewswire
News headline image
EVAX Stock Earnings: Evaxion Biotech Meets EPS for Q4 2023 ↗
EVAX stock results show that Evaxion Biotech met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Evaxion Announces Business Update and Full Year 2023 Financial Results
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Announces Closing of $15 Million Public Offering
From Evaxion Biotech
Via GlobeNewswire
News headline image
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. 
Via Benzinga
News headline image
Evaxion Biotech Announces Pricing of $15 Million Public Offering
From Evaxion Biotech
Via GlobeNewswire
News headline image
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Dow Edges Lower; US Composite PMI Rises In January ↗
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today? ↗
Evaxion Biotech revolutionizes cancer vaccine development, targeting AI-identified ERVs. Preclinical activities underway; Proof-of-Concept data expected by 2H 2024. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >